German Pavilion at
BIO 2020
08-11 June 2020 - San Diego, USA
Biotechnology Exhibition
News & Innovations
News and innovations published by German exhibitors
Current BioPark Financial Report 2019
The current development of life science companies in the Regensburg Bioregion demonstrates a stable number of companies and employees in East Bavaria. The new financial figures presented by BioPark Regensburg GmbH for 2019 make a count of 58 companies and…
Exhibitor: BioPark Regensburg GmbH
Further readingGerman company develops world´s first commercial test for China SARS virus
Duisburg, Germany 20.01.2020: At present, there is an outbreak of SARS virus called novel coronavirus 2020 going in China. Genekam Biotechnology AG has developed tests to detect this virus andrelated virus originating from bats. Genekam has developed one of first…
Exhibitor: Genekam Biotechnology AG
Further readingComprehensive services
Full dossiers for health technology assessments in Europe• European core values dossiers• Market analysis• Real-world analysis and analysis of care provision• Market access and pricing strategies• Clinical trials
Exhibitor: IGES Institut GmbH
Further readingMorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab
MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR) and Incyte Corporation (NASDAQ: INCY) announced today that the companies have entered into a collaboration and license agreement to further develop and commercialize MorphoSys' proprietary anti-CD19 antibody tafasitamab…
Exhibitor: MorphoSys AG
Further readingCATO RESEARCH ANNOUNCES MERGER WITH SMS-ONCOLOGY Combination Broadens Company’s Global Solutions Supporting Drug Development
DURHAM, NC – October 28, 2019 - Cato Research, LLC (CATO) announced today that it has merged with Specialized Medical Services-oncology BV (SMS-oncology) to bolster its portfolio of global solutions dedicated to supporting life science organizations with advancing drug development.…
Exhibitor: CATO Europe GmbH
Further readingCorporate company film
bioskin is your valuable partner for dermatological product development offering full services for global management of dermatological Phase I-IV drug and medical device trials. Headquartered in Hamburg, Germany, bioskin is unique in the understanding for both early and late phase…
Exhibitor: bioskin GmbH
Further readingpharmtrace – GCP-compliant clinical trial medical image management solution.
ERICA, our proprietary image management platform, provides a total image management solution that fulfils the rigorous GCP standards set by the EMEA and FDA for clinical trial data. ERICA can also be programmed to monitor and report study status (progress…
Exhibitor: pharmtrace klinische Entwicklung GmbH
Further readingpharmtrace – ERICA control and manage your clinical trial medical imaging.
ERICA, your flexible platform for the GCP-compliant collection, quality control, review and management of radiological and nuclear medicine images from clinical trials with the flexibility of up-to-date image visualization and analysis tools. Following extensive validation ERICA was launched in 2014.…
Exhibitor: pharmtrace klinische Entwicklung GmbH
Further readingpharmtrace – ERICA intelligent management of clinical trial medical imaging
Independent expertise for nuclear medicine, diagnostics and drug development clinical trials where medical imaging is a key clinical end-point. Experience and know-how to optimise the design and operational management of such clinical trials to generate GCP-compliant image data, including independent…
Exhibitor: pharmtrace klinische Entwicklung GmbH
Further reading